A Phase 1 Study of ATV-1601 in Patients With Advanced Cancer That Have AKT1 E17K Mutations
Atavistik Bio, Inc
Atavistik Bio, Inc
Varian, a Siemens Healthineers Company
LEO Pharma
IGF Oncology, LLC
sigma-tau i.f.r. S.p.A.
Celldex Therapeutics
Merck Sharp & Dohme LLC
Pharmacyclics LLC.